• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARROW INTERNATIONAL LLC ARROW PI PICC 2-L: 5FR X 55CM W/ 130CM HYDRO N; CATHETPATIENTER, INTRAVASCULAR, THER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARROW INTERNATIONAL LLC ARROW PI PICC 2-L: 5FR X 55CM W/ 130CM HYDRO N; CATHETPATIENTER, INTRAVASCULAR, THER Back to Search Results
Catalog Number PR-35552-HPHNL
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Erythema (1840); Pain (1994); Sepsis (2067)
Event Date 10/25/2022
Event Type  malfunction  
Event Description
The complaint is reported as: a patient with a double lumen picc was unwell at home.The picc site was accessed/documented as clean/dry/not red and no pain when used.Patient became increasingly unwell at home with tachycardia, pain, oedema, generally feeling unwell.Patient transferred to hospital.Ecg and obs taken but picc not assessed/accessed and no medical review at this time.Patient went for an urgent ctpa to rule out a pulmonary embolism.Picc connected to pressure injector but no assessment undertaken by rn involved (didn't take down dressing so not sure what site looked like) flushed device pre and post (no issues) and ct competed without any immediate issues.Transferred to unit and picc assessment then undertaken and erythema noted at insertion site and complained of site/chest pain when flushed.Patient meeting sepsis pathway criteria so picc not used.Peripheral cultures taken and then picc removed.It was noted picc intact on examination.No fracture/damage was documented in the patient's notes.Device was thrown away.Blood cultures and insertion site swab and tip sent for cultures and all negative.Picc was insitu for 15 days.It was reported the user facility was unsure if the patient was septic or had sirs.It was reported the medical intervention was to treat the patient's presenting symptoms and start the sepsis pathway although there was no confirmed central line associated infection.It was presumed the picc was the source of the patient's infection.The patient's current condition was reported as "ok, having treatment with a new line i believe".
 
Manufacturer Narrative
Qn#(b)(4).
 
Manufacturer Narrative
(b)(4).Complaint verification testing could not be performed as it was reported that the sample is not available for return.A device history record review was performed based on sales history, and one relevant findings was identified.A non-conformance was initiated for lot 13c22e1155 in regards to failure due to accumulation of tolerances.Without the sample returned, it cannot be confirmed if the failure mode of this complaint is the same as the non-conformance identified.Without the device to evaluate the complaint could not be confirmed and the probable cause could not be determined from the available information.Teleflex will continue to monitor and trend for reports of this nature.
 
Event Description
The complaint is reported as: a patient with a double lumen picc was unwell at home.The picc site was accessed/documented as clean/dry/not red and no pain when used.Patient became increasingly unwell at home with tachycardia, pain, oedema, generally feeling unwell.Patient transferred to hospital.Ecg and obs taken but picc not assessed/accessed and no medical review at this time.Patient went for an urgent ctpa to rule out a pulmonary embolism.Picc connected to pressure injector but no assessment undertaken by rn involved (didn't take down dressing so not sure what site looked like) flushed device pre and post (no issues) and ct competed without any immediate issues.Transferred to unit and picc assessment then undertaken and erythema noted at insertion site and complained of site/chest pain when flushed.Patient meeting sepsis pathway criteria so picc not used.Peripheral cultures taken and then picc removed.It was noted picc intact on examination.No fracture/damage was documented in the patient's notes.Device was thrown away.Blood cultures and insertion site swab and tip sent for cultures and all negative.Picc was insitu for 15 days.It was reported the user facility was unsure if the patient was septic or had sirs.It was reported the medical intervention was to treat the patient's presenting symptoms and start the sepsis pathway although there was no confirmed central line associated infection.It was presumed the picc was the source of the patient's infection.The patient's current condition was reported as "ok, having treatment with a new line i believe".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARROW PI PICC 2-L: 5FR X 55CM W/ 130CM HYDRO N
Type of Device
CATHETPATIENTER, INTRAVASCULAR, THER
Manufacturer (Section D)
ARROW INTERNATIONAL LLC
morrisville NC
Manufacturer (Section G)
ARROW INTERNATIONAL DE MEXICO S.A. DE C.V.
ave. washington 3701
colonia panamericana, chihuahua
chihuahua 31200
MX   31200
Manufacturer Contact
katharine tarpley
3015 carrington mill blvd
morrisville, NC 27560
MDR Report Key15814963
MDR Text Key307806757
Report Number9680794-2022-00721
Device Sequence Number1
Product Code LJS
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
K113277
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 10/25/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Catalogue NumberPR-35552-HPHNL
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 10/25/2022
Initial Date FDA Received11/17/2022
Supplement Dates Manufacturer Received12/13/2022
Supplement Dates FDA Received12/14/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
NOT REPORTED; NOT REPORTED
Patient Outcome(s) Hospitalization; Required Intervention;
-
-